RKIP enhances angiotensin II-stimulated signaling

Yasser El Faramawy, Xuebin Fu, Sara H. Agwa, Andreas Langer, Sherif S. Elzahwy, Ursula Quitterer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Protein kinase C-mediated phosphorylation converts the raf kinase inhibitor protein (RKIP) into an inhibitor of the G protein-coupled receptor kinase 2 (GRK2). As a result of GRK2 inhibition, RKIP prevents receptor desensitization and enhances signaling stimulated by the classical substrate of GRK2, i.e., the Gscoupled b-adrenergic receptor. The Gq/11-coupled angiotensin II AT1 receptor is another prototypic substrate of GRK2 in the cardiovascular system. However, the role of RKIP in Gq/11-coupled receptor signaling is not clear. Here, we show that overexpression of RKIP in kidney cells led to a significant increase of the AT1-stimulated calcium signal. In contrast, a phosphorylation-deficient mutant of RKIP that cannot act as GRK2 inhibitor had no effect. Analogously to the signal sensitization of kidney cells, RKIP increased the angiotensin II-stimulated hypertrophic response of cardiomyocytes. RNA interference studies revealed that endogenous RKIP levels of kidney cells and cardiomyocytes were sufficient to produce signal enhancement of AT 1. Thus, RKIP acts as a physiological enhancer of angiotensin II-stimulated signaling in kidney cells and cardiomyocytes.

Original languageEnglish (US)
Pages (from-to)71-78
Number of pages8
JournalForum on Immunopathological Diseases and Therapeutics
Issue number1
StatePublished - 2011


  • Angiotensin II AT1 receptor
  • BetaARK1
  • Cardiomyocytes
  • G protein-coupled receptor
  • GRK2
  • PEBP
  • RKIP
  • Raf kinase

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Genetics


Dive into the research topics of 'RKIP enhances angiotensin II-stimulated signaling'. Together they form a unique fingerprint.

Cite this